Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- ‘Metabolic syndrome’ label imprecise, but cardiometabolic risk is real Regina Schaffer
-
- Should the term ‘metabolic syndrome’ be changed to ‘circadian syndrome’?
- FDA approves first triple combination pill for type 2 diabetes
- Controversial pubertal blocker legislation may bring unintended consequences for children
- Blood test can predict final menstrual period Regina Schaffer
- Dual-hormone artificial pancreas ‘next logical treatment’ for type 1 diabetes Phil Neuffer
- Hypothyroidism, HT exert opposite risks for postmenopausal breast cancer Phil Neuffer
- Increased complications in latent autoimmune diabetes warrant ‘tailored screening strategies’ Regina Schaffer
- Maternal caffeine intake during pregnancy associated with pediatric abdominal, liver fat
-
- Obesity at younger age does not diminish bariatric surgery benefits Phil Neuffer
- Reducing HbA1c best strategy to avoid initial, subsequent CVD events in type 1 diabetes Phil Neuffer
- Weekly GH therapy may reduce treatment burden for adults with GH deficiency Regina Schaffer